Login / Signup

Intravenous tenecteplase for acute ischemic stroke between 4.5 and 6 h of onset (EXIT-BT2): Rationale and Design.

Yi-Han WangZhen-Ni GuoMing-Rui ChenZhi-Guo YaoThanh N NguyenJeffrey L SaverYi YangHui-Sheng Chen
Published in: European stroke journal (2024)
The results of EXIT-BT2 may determine whether intravenous TNK has a favorable risk/benefit profile in AIS between 4.5 and 6 h of onset.
Keyphrases
  • acute ischemic stroke
  • high dose